128 related articles for article (PubMed ID: 9272618)
41. Characterization of the chylomicron-remnant-recognition sites on parenchymal and Kupffer cells of rat liver. Selective inhibition of parenchymal cell recognition by lactoferrin.
van Dijk MC; Ziere GJ; van Berkel TJ
Eur J Biochem; 1992 Apr; 205(2):775-84. PubMed ID: 1315278
[TBL] [Abstract][Full Text] [Related]
42. Detection of LDL receptor by ligand blotting with chylomicron remnants labelled with colloidal gold.
Pal S; Elsegood CL; Proctor SD; Mamo JC
Ann Clin Biochem; 2000 Jul; 37 ( Pt 4)():471-8. PubMed ID: 10902863
[TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
Marais AD
Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
[TBL] [Abstract][Full Text] [Related]
44. Removal of chylomicron remnants in transgenic mice overexpressing normal and membrane-anchored hepatic lipase.
Lee SJ; Kadambi S; Yu KC; David C; Azhar S; Cooper AD; Choi SY
J Lipid Res; 2005 Jan; 46(1):27-35. PubMed ID: 15520453
[TBL] [Abstract][Full Text] [Related]
45. Low-Density Lipoprotein Receptor Signaling Mediates the Triglyceride-Lowering Action of Akkermansia muciniphila in Genetic-Induced Hyperlipidemia.
Shen J; Tong X; Sud N; Khound R; Song Y; Maldonado-Gomez MX; Walter J; Su Q
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1448-56. PubMed ID: 27230129
[TBL] [Abstract][Full Text] [Related]
46. Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease.
Mahley RW
Isr J Med Sci; 1996 Jun; 32(6):414-29. PubMed ID: 8682647
[TBL] [Abstract][Full Text] [Related]
47. Regulation of chylomicron remnant uptake in the human hepatoma cell-line Hep G2. Role of the low-density lipoprotein receptor.
Chen Q; Florén CH; Nilsson A; Infante R
Biochim Biophys Acta; 1991 May; 1083(2):173-8. PubMed ID: 1645203
[TBL] [Abstract][Full Text] [Related]
48. Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice.
Auger A; Truong TQ; Rhainds D; Lapointe J; Letarte F; Brissette L
Eur J Biochem; 2001 Apr; 268(8):2322-30. PubMed ID: 11298750
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist.
Willnow TE; Sheng Z; Ishibashi S; Herz J
Science; 1994 Jun; 264(5164):1471-4. PubMed ID: 7515194
[TBL] [Abstract][Full Text] [Related]
50. Interrelationship of triglycerides with lipoproteins and high-density lipoproteins.
Gotto AM
Am J Cardiol; 1990 Sep; 66(6):20A-23A. PubMed ID: 2203246
[TBL] [Abstract][Full Text] [Related]
51. Lipoprotein-deficient serum stimulates the uptake of chylomicron remnants in cultured rat hepatocytes.
Jensen E; Florén CH; Nilsson A
Scand J Clin Lab Invest; 1988 Oct; 48(6):553-6. PubMed ID: 3217758
[TBL] [Abstract][Full Text] [Related]
52. Recognition of chylomicron remnants and beta-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver alpha 2-macroglobulin-recognition site.
van Dijk MC; Ziere GJ; Boers W; Linthorst C; Bijsterbosch MK; van Berkel TJ
Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):863-70. PubMed ID: 1719960
[TBL] [Abstract][Full Text] [Related]
53. Binding and uptake of chylomicron remnants by primary and THP-1 human monocyte-derived macrophages: determination of binding proteins.
Elsegood CL; Pal S; Roach PD; Mamo JC
Clin Sci (Lond); 2001 Aug; 101(2):111-9. PubMed ID: 11473484
[TBL] [Abstract][Full Text] [Related]
54. Hepatocytic lipoprotein receptors and intracellular lipoprotein catabolism.
Havel RJ; Hamilton RL
Hepatology; 1988; 8(6):1689-704. PubMed ID: 2847970
[TBL] [Abstract][Full Text] [Related]
55. Decreased hepatic expression of the low-density lipoprotein (LDL) receptor and LDL receptor-related protein in aging rats is associated with delayed clearance of chylomicrons from the circulation.
Field PA; Gibbons GF
Metabolism; 2000 Apr; 49(4):492-8. PubMed ID: 10778874
[TBL] [Abstract][Full Text] [Related]
56. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
Botham KM; Wheeler-Jones CP
Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
[TBL] [Abstract][Full Text] [Related]
57. The effects of chylomicron remnants enriched in n-3 or n-6 polyunsaturated fatty acids on the transcription of genes regulating their uptake and metabolism by the liver: influence of cellular oxidative state.
Zheng X; Rivabene R; Cavallari C; Napolitano M; Avella M; Bravo E; Botham KM
Free Radic Biol Med; 2002 Jun; 32(11):1123-31. PubMed ID: 12031897
[TBL] [Abstract][Full Text] [Related]
58. Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing.
Mahley RW; Huang Y
J Clin Invest; 2007 Jan; 117(1):94-8. PubMed ID: 17200713
[TBL] [Abstract][Full Text] [Related]
59. Insulin stimulates the uptake of chylomicron remnants in cultured rat hepatocytes.
Jensen E; Florén CH; Nilsson A
Eur J Clin Invest; 1988 Jun; 18(3):226-32. PubMed ID: 3138124
[TBL] [Abstract][Full Text] [Related]
60. Factors affecting the impaired hepatic uptake of chylomicron remnants in the cholestatic rat.
Landin B; Nilsson A
Scand J Gastroenterol; 1987 Mar; 22(2):225-32. PubMed ID: 2437646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
